Hepatocellular carcinoma is highly refractory cancer which is resistant to conventional chemotherapy and radiotherapy, carrying a dismal prognosis. Although many anticancer drugs have been developed for treating HCC, sorafenib is the only effective treatment, but it only prolongs survival duration for about 3 months. Recently, oncolytic virotherapy has shown promising results in treating HCCs and the effects can be more enhanced by adopting immune modulatory molecules. This review discusses the current status of treating HCC and the effective strategy of oncolytic virus-based immunotherapy for the treatment of HCCs.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oR6PWG
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2o7K1Dm via IFTTT
-
AP ® United States Government and Politics 2014 Free-Response Questions © 2014 The College Board. College Board, Advanced Placement Program,...
-
You know the feeling: you're hanging out somewhere, you look across the room, and suddenly your stomach drops. You start to sweat. Your ...
-
Unit 5: Writing cohesively - Section index. This unit looks at the use of language strategies to create clear, cohesive writing. It shows yo...
-
9781421620831 1421620839 Coral Reef 2008 Square Wall - Wall 9780160782732 0160782732 Code of Federal Regulations, Title 27, Alcohol, Tobacco...
-
Introduction Crisis management is a critical organizational function. Failure can result in serious harm to stakeholders, losses for an orga...
-
Abstract This randomized and longitudinal in vivo study aimed to assess different protocols for the treatment of dentin hypersensitivity w...
-
About IRF. The Incentive Research Foundation (IRF), a private not-for-profit foundation, funds research studies and develops products servin...
-
918 quotes have been tagged as self-confidence: Edgar Allan Poe: ‘I have great faith in fools - self-confidence my friends will call it.’, R...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου